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21. Flu vaccine, made in Mexico:
1.1 The Mexican Public Health stakes:
Producing Flu Vaccine on its own 
territory will lead Mexico to be part 
of the few auto-sufficient countries 
worldwide, for seasonal Flu,         
as well as in case of Pandemic 
outbreak
1. Flu vaccine, made in Mexico:
1.2 The Technology Transfer challenge:
Starting grass-roots , to build a Vaccine plant to produce 
Influenza antigens in Ocoyoacac, Mexico state.
Seasonal Flu Vaccine should be available for Mexican 
population on 2012  
Technology Transfer from France to Mexico:
100 M€ Capital Expenditures
5,000 m2 floor area on a 5ha. land (cornfield)
100 new positions created (direct jobs)
31. Flu vaccine, made in Mexico:
Target 2012
1. Flu vaccine, made in Mexico:
1.3 Project status:
42. Vaccine Technology Transfer:
Key points to consider
2.1 Methodology & Guidelines:
2.1.1 Technology Transfer Definition
A Technology Transfer manufacturing process of a product 
from the transferring site to the receiving site. This includes 
all the associated knowledge, information and skills to be 
able to manufacture the product at the receiving site in 
compliance with approved dossiers and with same or better 
safety and potency than the sending unit
Technology transfer embodies both the transfer of 
documentation and the demonstrated ability of a Receiving 
Site to effectively perform the critical elements of 
transferred technology, to the satisfaction of all parties and 
any, or all, applicable regulatory bodies.
2. Vaccine Technology Transfer:
Key points to consider
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52.  Vaccine Technology Transfer
to Mexico: Key points to consider
2.2 Administrative procedures/steps:
In order to get all permits, legal & Regulatory authorizations, 
access to energies, …, in due time, 
the country specificities & administrations organizations should 
be known & relations should be managed accordingly.
A good address book is a key success factor/leverage
As an example, for a building permit in Mexico, one should 
follow thoroughly the entire pathway, considering 3 steps:
Municipality
State
Federal authorities 
2. Vaccine Technology Transfer:
Key points to consider
2.3 Partnering for Engineering & Construction:
To assess which Engineering companies have enough background 
& experience, with respect to the activity to be created; in this case, 
Bio-pharmaceutical Industry.
To check if the potential Engineering partners have experienced 
implementation of “big projects” while working with local contractors, 
in this case, Mexican / Latin America companies 
To check, as well, the robustness of Safety Policy, Program & Tools 
proposed by the Engineering companies
62. Vaccine Technology Transfer:
Key points to consider
2.4 Staffing Project & Future Manufacturing Operations:
To involve, from start, all contributive functions:
At Sending & Receiving Sites
Global Supportive functions: Business Development, Supply 
Chain, Finance, Legal, Quality, Regulatory,     
To build, from start, a long-term staffing plan, including Transfer 
Team & Operational Team, considering overlaps between both
To anticipate on recruitments and always consider teamwork skills & 
behavior as a discriminating criteria
To ensure that key people from the Transfer Team will stay until 
receiving Site self-reliance    
3. Conclusion / Headlights (1/2)
“As Health partner of Mexican Public authorities initiative, 
Sanofi Pasteur is committed to build a Flu Vaccine Site, on Mexican 
soil, in order for this country to be self-sufficient, for seasonal 
vaccination campaigns, as well as in case of Flu Pandemic event”
Commitment & enthusiasm from receiving Country, Authorities 
and People is a key leverage to fulfill and respect Project 
objective
Another Key Success Factor is to comprehend the specificities, 
culture, behaviors of the host Country and to adapt accordingly
73. Conclusion / Headlights (2/2)
Overall, the Key Success Factor is:                                      
Partnership, Partnership, Partnership, …
Mexican Health 
Authorities
+ Birmex
